Effects of GLP‐1 receptor agonists on cognitive function in patients with type 2 diabetes: A systematic review and meta‐analysis based on randomized controlled trials
Abstract Aims Patients with type 2 diabetes mellitus (T2DM) have a significantly increased risk of cognitive impairment, and the protective effects of traditional hypoglycaemic drugs on cognitive function remain unclear. This study systematically evaluated the neuroprotective effects of GLP-1 receptor agonists (GLP-1RAs) based on randomized controlled trial (RCT) evidence, aiming to provide key evidence-based insights […]
Can Ozempic help you cut back on alcohol? Researchers think so
Semaglutide, tirzepatide, and other GLP-1 drugs appear to slow alcohol absorption and blunt its intoxicating effects, according to new research. The study found participants on these medications felt less drunk despite consuming the same amount of alcohol. This could point to a safer, faster-acting way to help people reduce drinking—distinct from traditional treatments that target […]
FDA Approves Novo Nordisk’s Rybelsus Diabetes Pill to Reduce Heart Risk
Novo Nordisk(NVO) announced that the U.S. FDA has approved Rybelsus, the only oral GLP-1 medication available, for reducing the risk of major adverse cardiovascular events such as cardiovascular death, heart attack, or stroke in adults with type 2 diabetes who are at high risk for these events, whether they’ve had a prior CV event or […]
Viking Therapeutics (VKTX) Receives a Buy from Oppenheimer
Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the best healthcare stocks with the highest upside. Viking Therapeutics, Inc. (NASDAQ:VKTX) received a Buy rating from Oppenheimer’s Jay Olson on October 7, who assigned a $100 price target to the stock’s shares. H.C. Wainwright analyst Joseph Pantginis also reiterated a bullish stance on Viking Therapeutics, Inc. (NASDAQ:VKTX) […]
FDA Approves Novo Nordisk’s Rybelsus Diabetes Pill to Reduce Heart Risk
The drug, called Rybelsus, is the only oral GLP-1 medication available; European regulators granted a similar approval earlier this year The Food and Drug Administration approved Novo Nordisk’sNOVO.B-6.38%decrease; red down pointing triangle oral GLP-1 medication to reduce the risk of major …
HMM: GLP-1s May Throw Off Some Medical Scans — The latest quirk linked to GLP-1 receptor agonists
HMM: GLP-1s May Throw Off Some Medical Scans — The latest quirk linked to GLP-1 receptor agonists is of more concern to doctors than patients. “According to new research, the latest quirk of GLP-1 receptor agonists is that they may influence the interpretation of oncological fluorodeoxyglucose (FDG) PET-CT scans.”
Novo, Lilly’s shares drop as Trump vows weight-loss drug price cuts – Reuters
Novo, Lilly’s shares drop as Trump vows weight-loss drug price cuts Reuters Ozempic, Wegovy stocks wilt following Trump GLP-1 comments Axios Novo Nordisk Shares Fall as Trump Moves to Cut Price of Weight-Loss Drugs The Wall Street Journal Eli Lilly and Novo Nordisk stocks fall as Trump says he wants $150 price for GLP-1s CNBC Trump says Ozempic prices […]
Gemma Collins reveals agonising ‘gallbladder attack’ could have been caused by fat jabs after three stone weight loss
GEMMA Collins has revealed her agonising “gallbladder attack” could have been caused by fat jabs after her three stone weight loss. The former TOWIE star, 44, has gone from a size 26 to a size 20 in just three months since starting weight-loss injections. GLP-1 injections such as Ozempic, Wegovy and Mounjaro, have had a surge in…
GLP-1s vs. Weight Loss Surgery: Which Is Better for You?
Considering a GLP-1 (like Wegovy or Zepbound) or weight loss surgery? Explore benefits, risks, costs and eligibility for both options to find the best path to significant weight loss and improved health.
People Taking Ozempic Say Booze Just Doesn’t Hit Same | Research found that people taking GLP-1 receptor agonists — medications like Ozempic, Mounjaro, and Saxenda absorb alcohol more slowly and feel less drunk when drinking.
submitted by /u/chrisdh79 [link] [comments]